JDOC Short Volume

JPMorgan Healthcare Leaders ETF (JDOC) operates in the Financial Services sector, specifically the Asset Management industry, with a market capitalization near $12.0M, listed on NASDAQ, carrying a beta of 0.45 to the broader market. The fund primarily allocates its capital to the common stock of companies within the broad healthcare sector, specifically targeting businesses engaged in pharmaceuticals, biotechnology, healthcare services, health technology, medical technology, and life sciences. public since 2023-11-13.

Short volume measures the number of shares sold short on a given day as reported by FINRA. Tracking short volume relative to total volume helps identify unusual bearish sentiment or short-squeeze potential.

Latest Date
2026-07-16
Short Volume
4
Total Volume
9
Short %
44.44%
30-Day Avg Short %
39.57%

Showing 30 days of FINRA short volume data for JPMorgan Healthcare Leaders ETF.

Learn how short volume is reported and how to read the data →

Frequently asked JDOC short volume questions

What is the daily JDOC short volume?
As of Jul 16, 2026, JPMorgan Healthcare Leaders ETF (JDOC) short volume is 4 shares against 9 total reported volume, or 44.44% short-side. Short volume measures shares sold short during the day; it is flow, not inventory.
How is JDOC short volume reported?
FINRA publishes the Daily Short Sale Volume File for trades reported to FINRA TRFs and the FINRA/Nasdaq ADF on a T+1 basis. The headline figure is the count of shares that printed at the short-sale or short-exempt tick across all reporting venues for the symbol; each exchange separately publishes its own daily short-sale data file.
What does JDOC short volume tell options traders?
Daily short-sale flow is one input that helps disambiguate dealer-hedging activity from directional bear flow when the chain shows fresh customer call inventory. It is not a clean MM-only proxy: the headline number mixes directional shorting, options-MM delta-hedging, ETF-creation arbitrage, and convertible-arb hedging. Cross-check against gamma-exposure and OI changes for a cleaner read.